G2GBIO Inc. (KOSDAQ:456160)
32,100
-800 (-2.43%)
At close: Nov 17, 2026
G2GBIO Market Cap
G2GBIO has a market cap or net worth of 533.8 billion as of November 17, 2026. It is the 15,658th most valuable company in the world and the 401st biggest in South Korea. Its market cap has decreased by 65.33% in one year.
Market Cap
533.80B
Enterprise Value
n/a
Revenue
n/a
Global Rank
Country Rank
#401 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since August 14, 2025, G2GBIO's market cap has increased from 503.30B to 533.80B, an increase of 6.06%. That is a compound annual growth rate of 4.78%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2026 | 533.80B | -51.48% |
| Dec 30, 2025 | 1.10T | 118.59% |
| Aug 14, 2025 | 503.30B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ImmuneOncia Therapeutics | 215.71B |
| Vivozon Pharmaceutical | 167.26B |
| DAE HWA Pharmaceutical | 164.33B |
| HEM Pharma | 161.48B |
| GC WellBeing | 155.68B |
| Kyung Dong Pharmaceutical | 146.06B |
| CellBion | 144.28B |
| NOVAREX | 140.03B |